📈 Stocks
Galderma Shares Plunge After FDA Rejects Botox Rival Relfydess
(1 hour ago)
Galderma shares sank after the FDA rejected its Botox rival Relfydess, delaying U.S. market entry and strengthening AbbVie's grip on the aesthetics…